Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.36 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28681588 | 0.98 | ZDHHC20 (0.38) | ZDHHC20POLBTSHREP300SLC16A3 | |
| SCHEMBL28666287 | 0.94 | ZDHHC20 (0.43) | ZDHHC20POLBEP300SLC16A3SLC16A1 | |
| SCHEMBL5560249 | 0.94 | EP300 (0.40) | ZDHHC20POLBTSHREP300SLC16A3 | |
| SCHEMBL28665398 | 0.92 | ZDHHC20 (0.45) | ZDHHC20POLBEP300SLC16A3SLC16A1 | |
| SCHEMBL3240748 | 0.90 | CYP2C9 (0.33) | ZDHHC20POLBSLC16A3SLC16A1 | |
| SCHEMBL28667711 | 0.89 | POLB (0.33) | ZDHHC20POLBSLC16A3SLC16A1 | |
| SCHEMBL5912994 | 0.87 | ZDHHC20 (0.36) | ZDHHC20POLBEP300SLC16A3SLC16A1 | |
| SCHEMBL1274490 | 0.85 | POLB (0.38) | ZDHHC20POLBTSHRSLC16A3SLC16A1 | |
| SCHEMBL28676504 | 0.85 | ALDH1A1 (0.36) | POLBTSHR | |
| SCHEMBL30580 | 0.85 | CYP2C9 (0.38) | POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | claimed |
| US-20150232690-A1 | OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME | UT-BATTELLE, LLC (US) | 2015-08-20 | — | — | US | claimed |
| EP-0886507-B2 | MONOMERIC COMPOSITIONS EFFECTIVE AS WOUND CLOSURE DEVICES | ETHICON INC (US) | 2013-03-06 | — | — | EP | claimed |
| EP-0886507-B1 | MONOMERIC COMPOSITIONS EFFECTIVE AS WOUND CLOSURE DEVICES | CLOSURE MEDICAL CORP (US) | 2007-09-26 | — | — | EP | claimed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| EP-3947586-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20220033544-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2022-02-03 | — | — | US | disclosed |
| WO-2020206405-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-10-08 | — | — | WO | disclosed |
| US-20180271505-A1 | Scaffolds for Joining Layers of Tissue at Discrete Points | ETHICON, INC. | 2018-09-27 | — | — | US | disclosed |
| EP-2999689-B1 | CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-10-04 | — | — | EP | disclosed |
| US-20100035997-A1 | KIT FOR APPLYING A POLYMERIZABLE ADHESIVE COMPOSITION TO TISSUES | BROADLEY KENNETH N | 2010-02-11 | — | — | US | disclosed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | disclosed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | disclosed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | disclosed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035997-A1 | KIT FOR APPLYING A POLYMERIZABLE ADHESIVE COMPOSITION TO TISSUES | KIT, TEKT1, CUTA | ZDHHC20 3370/4885POLB 1476/4885TSHR 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.